Sclerosing Agents in the Treatment of Telangiectasia: Comparison of the Clinical and Histologic Effects of Intravascular Polidocanol, Sodium Tetradecyl Sulfate, and Hypertonic Saline in the Dorsal Rabbit Ear Vein Model

Archives of Dermatology

Volumn 123, Issue 9, 1987, Pages 1196-1201

  Goldman, Mitchel P ^a   Kaplan, Richard P ^a   Oki, Lisa N ^a   Cavender, Patricia A ^a   Strick, Richard A ^a   Bennett, Richard G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ANIMAL EXPERIMENT; CARDIOVASCULAR SYSTEM; DRUG EFFICACY; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCLEROTHERAPY; TELANGIECTASIA; THERAPY;

ANIMALS; EAR; FATTY ALCOHOLS; INJECTIONS, INTRAVENOUS; NECROSIS; POLYETHYLENE GLYCOLS; RABBITS; SALINE SOLUTION, HYPERTONIC; SODIUM CHLORIDE; SODIUM TETRADECYL SULFATE; TELANGIECTASIS; VEINS;

EID: 84943447172     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1987.01660330107021     Document Type: Article

References (33)

1. Biegeleisen HI: The evaluation of sodium morrhuate therapy in varicose veins: A critical study. Surg Gynecol Obstet 1933;57:696–700.
2. Dick ET: The treatment of varicose veins. NZ Med J 1966; 65:310–313.
3. Biegeleisen HI, Biegeleisen RM: The current status of sclerotherapy for varicose veins. Clin Med 1976;83:24–31.
4. Tretbar LL: Spider angiomata: Treatment with sclerosant injections. J Kansas Med Soc 1978;79:198–200.
5. Shields JL, Jansen GT: Therapy for superficial telangiectasias of the lower extremities. J Dermatol Surg Oncol 1982;8:857–860.
6. Mantse L: A mild sclerosing agent for telangiectasias. J Dermatol Surg Oncol 1985;11:855.
7. Foley WT: The eradication of venous blemishes. Cutis 1975;15:665–668.
8. Alderman DB: Therapy for essential cutaneous telangiectasias. Postgrad Med 1977;61:91–95.
9. Chrisman BB: Treatment of venous ectasias with hypertonic saline. Hawaii Med J 1982;41:406–408.
10. Bodian EL: Techniques of sclerotherapy for sunburst venous blemishes. J Dermatol Surg Oncol 1985;11:696–704.
11. Jaquier JJ, Loretan RM: Clinical trials of a new sclerosing agent, aethoxysklerol. Soc Fran Phleb 1969;22:383–385.
12. Eichenberger H: Results of phlebosclerosation with hydroxypolyethoxydodecane. Zentralbl Phlebol 1969;8:181–183.
13. Ouvry P, Chandet A, Guillerot E: First impressions of aethoxysklerol. Phlebologie 1978;31:75–77.
14. Cacciatore E: Experience of sclerotherapy with aethoxysklerol. Minerva Cardioangiol 1979;27:255–262.
15. Jacobesen BH: Aethoxysklerol: A new sclerosing agent for varicose veins. Ugeskr Laeger 1974;136:532–534.
16. Amblard P: Our experience with aethoxysklerol. Phlebologie 1977;30:213–215.
17. Lufkin NH, McPheeters HO: Pathological studies on injected varicose veins. Surg Gynecol Obstet 1932;54:511–517.
18. Wolf E: Die Histologischen Veranderungen der venen nach intravenosen sub Limatein Spritzungen. Med Klin 1920;16:806–808.
19. Kern HM, Angle LW: The chemical obliteration of varicose veins: A clinical and experimental study. JAMA 1929;93:595–602.
20. De Takats G, Quint H: The injection treatment of varicose veins. Surg Gynecol Obstet 1930;50:545–561.
21. Regard GL: The treatment of varicosities by sclerosing injections. Rev Med Suisse Romande 1925;65:102–107.
22. Reiner L: The activity of anionic surface active compounds in producing vascular obliteration. Proc Soc Exp Biol Med 1946;62:49–54.
23. Imhoff E, Stemmer R: Classification and mechanism of action of sclerosing agents. Soc Fran Phleb 1969;22:143–148.
24. Dexo SA France: Product insert description on hydroxypolyethoxydodecane. Received with correspondence, May 1985.
25. Kreussler and Co. GMbH: Product insert for aethoxysklerol. Chemische Fabrik, D-6200 Wiesbaden Biebrich, 1985.
26. Doerffel: Klinisches und experimentelles über Venenverodung mit Kochsalzlosung und Traubenzucker. Dtsch Med Wochenschr 1927;53:901–902.
27. Binet L, Verne J: Evolution histo-physiologie de la veine a la suite de son obliteration experimentale. Presse Med 1925;1:761–765.
28. Schwartz E, Ratschow M: Experimentelle und klinische Erfahrungen bei der kunstlichen Verodung von Varicen. Arch Klin Chir 1929;156:720–735.
29. Biegeleisen HI: Fatty acid solutions for the injection treatment of varicose veins: An evaluation of four new solutions. Ann Surg 1937;105:610–615.
30. McPheeters HO, Anderson JK: Injection Treatment of Varicose Veins and Hemorrhoids. Philadelphia, FA Davis Co Publishers, 1938.
31. Schneider W, Fischer H: Fixierung und bindegewebige Organization artefizieller thromben bei der Varizenuerodung. Dtsch Med Wochenschr 1964;89:2410–2412.
32. Schneider W: Contribution to the history of the sclerosing treatment of varices and to its anatomo-pathologic study. Soc Fran Phlebol 1965;18:117–130.
33. Dietrich VHP, Sinapius D: Experimental endothelial damage by varicosclerosation drugs. Arzneimittelforschung 1968; 18:116–120.